These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7791960)

  • 1. Involvement of vasopressin and corticotropin-releasing hormone in VIP- and PHI-induced secretion of ACTH and corticosterone.
    Alexander LD; Sander LD
    Neuropeptides; 1995 Mar; 28(3):167-73. PubMed ID: 7791960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIP antagonist demonstrates differences in VIP- and PHI-mediated stimulation and inhibition of ACTH and corticosterone secretion in rats.
    Alexander LD; Sander LD
    Regul Pept; 1995 Nov; 59(3):321-33. PubMed ID: 8577937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin pressor receptor-mediated activation of HPA axis by acute ethanol stress in rats.
    László FA; Varga C; Pávó I; Gardi J; Vecsernyés M; Gálfi M; Morschl E; László F; Makara GB
    Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R458-65. PubMed ID: 11208575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally administered murine-leptin stimulates the hypothalamus-pituitary- adrenal axis through arginine-vasopressin.
    Morimoto I; Yamamoto S; Kai K; Fujihira T; Morita E; Eto S
    Neuroendocrinology; 2000 Jun; 71(6):366-74. PubMed ID: 10878498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress.
    Tilders FJ; Berkenbosch F; Vermes I; Linton EA; Smelik PG
    Fed Proc; 1985 Jan; 44(1 Pt 2):155-60. PubMed ID: 2981737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin.
    Grino M; Paulmyer-Lacroix O; Faudon M; Renard M; Anglade G
    Endocrinology; 1994 Dec; 135(6):2549-57. PubMed ID: 7988443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vasopressin receptor antagonist dPTyr (Me) AVP does not prevent stress-induced ACTH and corticosterone release.
    Mormède P
    Nature; 1983 Mar 24-30; 302(5906):345-6. PubMed ID: 6300679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine- and stress-induced secretion of ACTH and beta-endorphin: involvement of corticotropin-releasing hormone and vasopressin.
    Kjaer A; Knigge U; Bach FW; Warberg J
    Neuroendocrinology; 1992 Sep; 56(3):419-28. PubMed ID: 1331840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Scott LV; Dinan TG
    Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
    Hohnloser J; Von Werder K; Müller OA
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses of the rat pituitary-adrenal axis to hypotensive infusions of corticotropin-releasing factor, vasoactive intestinal peptide and other depressor agents.
    Pralong FP; Corder R; Gaillard RC
    Regul Pept; 1991 Feb; 32(2):217-26. PubMed ID: 1852030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender difference in hypothalamic-pituitary-adrenal axis response to alcohol in the rat: activational role of gonadal steroids.
    Ogilvie KM; Rivier C
    Brain Res; 1997 Aug; 766(1-2):19-28. PubMed ID: 9359583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
    Kent P; Anisman H; Merali Z
    Neuroendocrinology; 2001 Mar; 73(3):203-14. PubMed ID: 11307039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis.
    Schmidt ED; Janszen AW; Wouterlood FG; Tilders FJ
    J Neurosci; 1995 Nov; 15(11):7417-26. PubMed ID: 7472494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R; Anconetani B; Chattat R; Biscotti M; Spinucci G; Casimirri F; Vicennati V; Carcello A; Labate AM
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.